Market Access Matters
by Access Infinity
Latest episode
Understanding Payer Perceptions with Megan O'Brien
Understanding Payer Perceptions with Megan O'Brien
About this podcast
Brought to you by the team at Access Infinity, this podcast shines a spotlight on the people in market access. In each episode we interview a different industry professional to discover their journey into market access, what inspires them and what they feel is on the horizon for this this ever-changing and exciting industry.
Episodes
The newest 20 of 33 episodes
- Understanding Payer Perceptions with Megan O'Brien · 18 min · Season 4 Episode 10In this episode, we hear from Megan O'Brien, Associate Director at Access Infinity, to explore why understanding payer perception is so difficult to capture in a structured way…
- Pricing Under Pressure: What MFN Really Means for Global Strategy · 40 min · Season 4 Episode 9Most Favored Nation (MFN) pricing has taken over conversations at conferences, client meetings, and boardrooms alike, but what does it actually mean in practice? In this episode…
- Navigating Global Policy Shifts with Nikhil Taxak · 27 min · Season 4 Episode 8In this episode we sit down with Nikhil Taxak, Head of Pricing and Market Access Data Analytics at Access Infinity, to explore the rapidly evolving market access landscape. From…
- Beyond the Headlines: Understanding MFN's True Impact on Market Access · 19 min · Season 4 Episode 7In this episode, we're joined by Louisa Oliver Byrne, Senior Consultant at Access Infinity. We learn about the complexities of the Most Favored Nation (MFN) policy and its…
- Revolutionary Strategies in Orphan Drug Development with Isabel Rubio · 18 min · Season 4 Episode 6In this episode, we invite Access Infinity Partner, Isabel Rubio back to the podcast to explore the unique challenges and innovative solutions reshaping market access and pricing…
- Elevating launch excellence: The strategic value of early market access involvement with Lizzie Shanahan, Sanofi · 30 min · Season 4 Episode 5In this insightful episode we speak with Lizzie Shanahan, Global Access AI Strategy Lead at Sanofi. With over six years' experience at Sanofi and a rich background in commercial…
- Getting ready for the JCA: Why cross-functional collaboration matters with Silvy Mardiguian, BeiGene · 19 min · Season 4 Episode 4In this episode, we speak with Silvy Mardiguian, Senior Director and Head of HEOR for Europe & New Markets at BeiGene. Silvy has been co-leading BeiGene’s preparedness and…
- The rise of multi-stakeholder capitalism in market access with Jie Shen, CSL · 14 min · Season 4 Episode 3In this episode we chat with Jie Shen, who is Vice President Global Head Market Access at CSL. Having started her career in pharma before the market access function existed, Jie…
- Authentic leadership in Market Access with Katrin Jack, Galderma · 42 min · Season 4 Episode 2We're kicking off 2025 with a fantastic podcast episode featuring Katrin Jack, Global Access Strategy Head at Galderma and President of the Healthcare Businesswomen's Association…
- Market Access in emerging markets with Ezgi Erdogan, GSK · 15 min · Season 4 Episode 1In this episode we speak with Ezgi Erdogan who is Oncology Market Access Director for Emerging Markets at GSK. In this discussion, we cover the unpredictability of emerging…
- Why Market Access requires unique thinking with UCB's Pauline Payen · 28 min · Season 3 Episode 8In this episode, we sit down with Pauline Payen, Director and Global Payer Strategy Lead for UCB’s Early Portfolio. Pauline shares her pragmatic insights into navigating the…
- The role of resilience in market access with Rupert Gale from GSK · 29 min · Season 3 Episode 7In this episode we're joined by GSK's Head of Market Access for General Medicines, Rupert Gale. Rupert has been in pharma for over 27 years and is still going strong! In this…
- Exploring value demonstration in market access with Korinna Karampampa, CSL Behring · 14 min · Season 3 Episode 6Korinna Karampampa, who is Director Market Access and Pricing at CSL Behring, joins this episode to share her views on sustainable economic development. Korinna shares what led…
- Connecting the dots: Market access in the biotech industry with Ning Lu, Blueprint Medicines · 16 min · Season 3 Episode 6In this episode we're joined by our first guest from Biotech - Ning Lu, who is Associate Director, International Pricing & Market Access at Blueprint Medicines. Ning shares her…
- What it takes to thrive as a strategic partner in market access with Marco Rauland, Merck KGaA · 18 min · Season 3 Episode 5There’s no doubt that Market Access and Pricing leaders are fast becoming strategic partners in helping their wider organisations to understand the critical role of the function…
- Yvonne Hilsky, Moderna, on why it's important to understand the building blocks of market access. · 19 min · Season 3 Episode 4In this episode we're joined by Yvonne Hilsky who is Director of Market Access at Moderna. Having spent over 30 years in industry, Yvonne shares her views on what it takes to be…
- Raising awareness on Disability with Shubham Jadhav · 33 min · Season 3 Episode 3In this special episode which coincides with Disability Pride Month, we're joined by Senior Analyst Shubham Jadhav. Shubham has Becker Muscular Dystrophy (BMD) which is a form of…
- Exploring Canada's market access landscape with Sam Stankovic, Incyte Biosciences Canada · 20 min · Season 3 Episode 2Sam is Head of Market Access Canada at Incyte Biosciences Canada and joins the podcast to discuss the evolving market access landscape in Canada. As part of his conversation with…
- Market access challenges and changes: Joao Carrasco talks data, AI and predicting uncertainties · 26 min · Season 3 Episode 1In this episode we're joined by Joao Carrasco, Director, Global Market Access Team at Bayer Pharmaceuticals. With a 12+ year career spanning both HEOR and Market Access…
- Sanofi's Becky Germino on communicating value, AI and the role of HEOR in supporting access & pricing leaders · 30 min · Season 2 Episode 6In this episode we look at market access through a different lens. We're joined by Becky Germino who has extensive experience in HEOR across a broad range of pharma…
